Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in the Human Eye

References

• Oran D, Topol E. Prevalence of Asymptomatic SARS-CoV-2 Infection. Ann Intern Med. 2020;173(5):362–367. doi:10.7326/M20-3012.
   PubMed Web of Science ®Google Scholar
• Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–2336. doi: 10.1056/NEJMoa2007016.
   Google Scholar
• Rodriguez-Morales A, Cardona-Ospina J, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016/j.tmaid.2020.101623.
   Google Scholar
• Weiss P, Murdoch D. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014–1015. doi: 10.1016/S0140-6736(20)30633-4.
   Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Med. 2020;180(7):934. doi:10.1001/jamainternmed.2020.0994.
   PubMed Web of Science ®Google Scholar
• Lu C-W, Liu X-F, Jia Z-F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39–e39. doi:10.1016/S0140-6736(20)30313-5.
   PubMed Web of Science ®Google Scholar
• Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020;173(3):242–243. doi:10.7326/M20-1176.
   PubMed Web of Science ®Google Scholar
• Aiello F, Gallo Afflitto G, Mancino R, et al. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye. 2020;34(7):1206–1211. doi:10.1038/s41433-020-0926-9.
   PubMed Web of Science ®Google Scholar
• Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm. 2020;28(5):726–734. doi:10.1080/09273948.2020.1772313.
   PubMed Web of Science ®Google Scholar
• Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020;98(3):223. doi:10.1111/aos.14413.
   Google Scholar
• Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725.
   Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–751. doi:10.1136/bjophthalmol.2020.316304.
   Google Scholar
• Bettach E, Zadok D, Weill Y, Brosh K, Hanhart J. Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection. J Med Virol. 2020;93(1):139-140. doi:10.1002/jmv.26229.
   Google Scholar
• Benito-Pascual B, Gegúndez JA, Díaz-Valle D, et al. Panuveitis and optic neuritis as a possible initial presentation of the Novel Coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922–925. doi:10.1080/09273948.2020.1792512.
   PubMed Web of Science ®Google Scholar
• Acharya S, Diamond M, Anwar S, Glaser A, Tyagi P. Unique case of central retinal artery occlusion secondary to COVID-19 disease. IDCases. 2020;21:e00867. doi:10.1016/j.idcr.2020.e00867.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. 2020;382:1708–1720. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032.
   Google Scholar
• Pirraglia MP, Ceccarelli G, Cerini A, et al. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020;10(1):17419. doi:10.1038/s41598-020-74446-6.
   PubMed Web of Science ®Google Scholar
• Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:10.1016/S0140-6736(20)31014-X.
   PubMed Web of Science ®Google Scholar
• Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi:10.1016/j.eclinm.2020.100550.
   PubMedGoogle Scholar
• Bayyoud T, Iftner A, Iftner T, et al. Absence of severe acute respiratory syndrome-coronavirus-2 RNA in ocular tissues. Am J Ophthalmol Case Rep. 2020;19:100805. doi:10.1016/j.ajoc.2020.100805.
   Google Scholar
• Kumaran N, Sekhawat V, Mahadeva U, Green A, Douthwaite S, Wong R. Absence of severe acute respiratory syndrome coronavirus 2 in ocular postmortem studies. Can J Ophthalmol. 2021;56(2):142–143. doi:10.1016/j.jcjo.2020.10.009
   PubMed Web of Science ®Google Scholar
• Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725. doi:10.1080/09273948.2020.1770301.
   PubMed Web of Science ®Google Scholar
• Doherty MJ. Ocular manifestations of feline infectious peritonitis. J Am Vet Med Assoc. 1971;159(4):417-24.
   Google Scholar
• Hök KJAVS. Morbidity, mortality and coronavirus antigen in previously coronavirus free kittens placed in two catteries with feline infectious peritonitis. Acta Veterinaria Scandinavica. 1993;34(2):203–210.doi:10.1186/BF03548211.
   Google Scholar
• Robbins SG, Detrick B, Hooks JJ. Retinopathy following intravitreal injection of mice with MHV strain JHM. In: Cavanagh D, Brown T.D.K, eds. Coronaviruses and Their Diseases. Advances in Experimental Medicine and Biology, vol 276. Boston, MA: Springer; 1990:519–524. https://doi.org/10.1007/978-1-4684-5823-7_72
   Google Scholar
• Seah I, R A. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:10.1080/09273948.2020.1738501.
   Google Scholar
• Shindler KS, Kenyon LC, Dutt M, Hingley ST, Sarma J. Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus. J Virol. 2008;82(17):8882–8886. doi:10.1128/JVI.00920-08.
   Google Scholar
• Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145.
   Google Scholar
• Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94(7):e00127-20. doi:10.1128/JVI.00127-20.
   Web of Science ®Google Scholar
• Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562–569. doi:10.1038/s41564-020-0688-y.
   Google Scholar
• Senanayake P, Drazba J, Shadrach K, et al. Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci. 2007;48(3):3301–3311.  doi:10.1167/iovs.06-1024.
   Google Scholar
• Holappa M, Valjakka J, Vaajanen A. Angiotensin (1-7) and ACE2,“the hot spots” of renin-angiotensin system, detected in the human aqueous humor. Open Ophthalmol J. 2015;9:28.
   PubMed Web of Science ®Google Scholar
• Tao L, Qiu Y, Fu X, et al. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium. J Neuroinflammation. 2016;13:35. doi:10.1186/s12974-016-0489-7.
   Google Scholar
• Corman V, Bleicker T, Brünink S, Drosten C, Zambon M. World Health Organization %J Geneva: world Health Organization J. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR. 2020;p. 13.
   Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127(7):982–983. doi:10.1016/j.ophtha.2020.04.028
   Google Scholar
• Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19? J Med Virol. 2021;93:383–388.
   PubMed Web of Science ®Google Scholar
• Atum M, Boz AAE, Çakır B, et al. Evaluation of conjunctival Swab PCR results in patients with SARS-CoV-2 infection. Ocul Immunol Inflamm. 2020;28:745–748. doi:10.1080/09273948.2020.1775261.
   PubMed Web of Science ®Google Scholar
• Li X, Chan J, Li K, et al. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection. 2020;49(2):257-265. doi:10.1007/s15010-020-01524-2.
   Web of Science ®Google Scholar
• Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98:e951–e959. doi:10.1111/aos.14472.
   Google Scholar
• Gascon P, Briantais A, Bertrand E, et al. Covid-19-associated retinopathy: a case report. Ocul Immunol Inflamm. 2020;28(8):1293-1297. doi:10.1080/09273948.2020.1825751.
   Google Scholar
• François J, Collery A, Hayek G, et al. Coronavirus disease 2019–associated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2020;139(2):247. doi:10.1001/jamaophthalmol.2020.5695.
   Web of Science ®Google Scholar
• Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020;194:101–115. doi:10.1016/j.thromres.2020.06.029.
   PubMed Web of Science ®Google Scholar
• Araujo-Silva Ca, Marcos AAA, Marinho PM, et al. Presumed SARS-CoV-2 viral particles in the human retina of patients with COVID-19. JAMA Ophthalmol. 2021. doi:10.1001/jamaophthalmol.2021.2795.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang L, Yin Y, Yang E. Systematic analysis of gene expression patterns associated with postmortem interval in human tissues. Sci Rep. 2017;7:1–12. https://doi.org/10.1038/s41598-017-05882-0
   Google Scholar
• Kostoulas P, Eusebi P, Hartnack S. Diagnostic accuracy estimates for COVID-19 real-time polymerase chain reaction and lateral flow immunoassay tests with bayesian latent-class models. Am J Epidemiol. 2021;190:1689–1695. doi:10.1093/aje/kwab093.
   Google Scholar
• Butler-Laporte G, Lawandi A, Schiller I, et al. Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021;181:353–358. doi:10.1001/jamainternmed.2020.8876.
   Google Scholar